메뉴 건너뛰기




Volumn 1, Issue 7, 2013, Pages 524-533

Once-daily indacaterol versus tiotropium for patients with severe chronic obstructive pulmonary disease (INVIGORATE): A randomised, blinded, parallel-group study

Author keywords

[No Author keywords available]

Indexed keywords

CORTICOSTEROID; INDACATEROL; TIOTROPIUM BROMIDE; BRONCHODILATING AGENT; INDAN DERIVATIVE; QUINOLONE DERIVATIVE; SCOPOLAMINE DERIVATIVE;

EID: 84883461908     PISSN: 22132600     EISSN: None     Source Type: Journal    
DOI: 10.1016/S2213-2600(13)70158-9     Document Type: Article
Times cited : (221)

References (30)
  • 1
    • 84856118942 scopus 로고    scopus 로고
    • Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease
    • Keating GM Tiotropium bromide inhalation powder: a review of its use in the management of chronic obstructive pulmonary disease. Drugs 2012, 72:273-300.
    • (2012) Drugs , vol.72 , pp. 273-300
    • Keating, G.M.1
  • 2
    • 84857283681 scopus 로고    scopus 로고
    • Indacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease
    • McKeage K Indacaterol: a review of its use as maintenance therapy in patients with chronic obstructive pulmonary disease. Drugs 2012, 72:543-563.
    • (2012) Drugs , vol.72 , pp. 543-563
    • McKeage, K.1
  • 3
    • 0037677450 scopus 로고    scopus 로고
    • Time course of recovery of health status following an infective exacerbation of chronic bronchitis
    • Spencer S, Jones PW Time course of recovery of health status following an infective exacerbation of chronic bronchitis. Thorax 2003, 58:589-593.
    • (2003) Thorax , vol.58 , pp. 589-593
    • Spencer, S.1    Jones, P.W.2
  • 4
    • 2442552129 scopus 로고    scopus 로고
    • Impact of preventing exacerbations on deterioration of health status in COPD
    • Spencer S, Calverley PM, Burge PS, Jones PW Impact of preventing exacerbations on deterioration of health status in COPD. Eur Respir J 2004, 23:698-702.
    • (2004) Eur Respir J , vol.23 , pp. 698-702
    • Spencer, S.1    Calverley, P.M.2    Burge, P.S.3    Jones, P.W.4
  • 5
    • 48949103222 scopus 로고    scopus 로고
    • Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study
    • Celli BR, Thomas NE, Anderson JA, et al. Effect of pharmacotherapy on rate of decline of lung function in chronic obstructive pulmonary disease: results from the TORCH study. Am J Respir Crit Care Med 2008, 178:332-338.
    • (2008) Am J Respir Crit Care Med , vol.178 , pp. 332-338
    • Celli, B.R.1    Thomas, N.E.2    Anderson, J.A.3
  • 6
    • 0036794862 scopus 로고    scopus 로고
    • Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease
    • Donaldson GC, Seemungal TA, Bhowmik A, Wedzicha JA Relationship between exacerbation frequency and lung function decline in chronic obstructive pulmonary disease. Thorax 2002, 57:847-852.
    • (2002) Thorax , vol.57 , pp. 847-852
    • Donaldson, G.C.1    Seemungal, T.A.2    Bhowmik, A.3    Wedzicha, J.A.4
  • 7
    • 33645573320 scopus 로고    scopus 로고
    • COPD exacerbations. 3: Pathophysiology
    • O'Donnell DE, Parker CM COPD exacerbations. 3: Pathophysiology. Thorax 2006, 61:354-361.
    • (2006) Thorax , vol.61 , pp. 354-361
    • O'Donnell, D.E.1    Parker, C.M.2
  • 8
    • 84871253503 scopus 로고    scopus 로고
    • The role of bronchodilator tr.eatment in the prevention of exacerbations of COPD
    • Wedzicha JA, Decramer M, Seemungal TA The role of bronchodilator tr.eatment in the prevention of exacerbations of COPD. Eur Respir J 2012, 40:1545-1554.
    • (2012) Eur Respir J , vol.40 , pp. 1545-1554
    • Wedzicha, J.A.1    Decramer, M.2    Seemungal, T.A.3
  • 9
    • 80053090797 scopus 로고    scopus 로고
    • Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD
    • Buhl R, Dunn LJ, Disdier C, et al. Blinded 12-week comparison of once-daily indacaterol and tiotropium in COPD. Eur Respir J 2011, 38:797-803.
    • (2011) Eur Respir J , vol.38 , pp. 797-803
    • Buhl, R.1    Dunn, L.J.2    Disdier, C.3
  • 10
    • 77954800883 scopus 로고    scopus 로고
    • Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium
    • Donohue JF, Fogarty C, Lotvall J, et al. Once-daily bronchodilators for chronic obstructive pulmonary disease: indacaterol versus tiotropium. Am J Respir Crit Care Med 2010, 182:155-162.
    • (2010) Am J Respir Crit Care Med , vol.182 , pp. 155-162
    • Donohue, J.F.1    Fogarty, C.2    Lotvall, J.3
  • 11
    • 77957254369 scopus 로고    scopus 로고
    • Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium
    • Vogelmeier C, Ramos-Barbon D, Jack D, et al. Indacaterol provides 24-hour bronchodilation in COPD: a placebo-controlled blinded comparison with tiotropium. Respir Res 2010, 11:135.
    • (2010) Respir Res , vol.11 , pp. 135
    • Vogelmeier, C.1    Ramos-Barbon, D.2    Jack, D.3
  • 12
    • 84888675464 scopus 로고    scopus 로고
    • Global Initiative for Obstructive Lung Disease, (accessed March 6, 2013).
    • Global Strategy for the Diagnosis, Management and Prevention of COPD (2013) Global Initiative for Obstructive Lung Disease, (accessed March 6, 2013). http://www.goldcopd.org/uploads/users/files/GOLD_Report_2013_Feb20.pdf.
    • Global Strategy for the Diagnosis, Management and Prevention of COPD (2013)
  • 13
    • 53749102775 scopus 로고    scopus 로고
    • A 4-year trial of tiotropium in chronic obstructive pulmonary disease
    • Tashkin DP, Celli B, Senn S, et al. A 4-year trial of tiotropium in chronic obstructive pulmonary disease. N Engl J Med 2008, 359:1543-1554.
    • (2008) N Engl J Med , vol.359 , pp. 1543-1554
    • Tashkin, D.P.1    Celli, B.2    Senn, S.3
  • 14
    • 79953166862 scopus 로고    scopus 로고
    • Tiotropium versus salmeterol for the prevention of exacerbations of COPD
    • Vogelmeier C, Hederer B, Glaab T, et al. Tiotropium versus salmeterol for the prevention of exacerbations of COPD. N Engl J Med 2011, 364:1093-1103.
    • (2011) N Engl J Med , vol.364 , pp. 1093-1103
    • Vogelmeier, C.1    Hederer, B.2    Glaab, T.3
  • 19
    • 0021256105 scopus 로고
    • The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes
    • Mahler DA, Weinberg DH, Wells CK, Feinstein AR The measurement of dyspnea. Contents, interobserver agreement, and physiologic correlates of two new clinical indexes. Chest 1984, 85:751-758.
    • (1984) Chest , vol.85 , pp. 751-758
    • Mahler, D.A.1    Weinberg, D.H.2    Wells, C.K.3    Feinstein, A.R.4
  • 20
    • 0026871146 scopus 로고
    • A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire
    • Jones PW, Quirk FH, Baveystock CM, Littlejohns P A self-complete measure of health status for chronic airflow limitation. The St. George's Respiratory Questionnaire. Am Rev Respir Dis 1992, 145:1321-1327.
    • (1992) Am Rev Respir Dis , vol.145 , pp. 1321-1327
    • Jones, P.W.1    Quirk, F.H.2    Baveystock, C.M.3    Littlejohns, P.4
  • 22
    • 0037425745 scopus 로고    scopus 로고
    • Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial
    • Calverley P, Pauwels R, Vestbo J, et al. Combined salmeterol and fluticasone in the treatment of chronic obstructive pulmonary disease: a randomised controlled trial. Lancet 2003, 361:449-456.
    • (2003) Lancet , vol.361 , pp. 449-456
    • Calverley, P.1    Pauwels, R.2    Vestbo, J.3
  • 23
    • 37849011194 scopus 로고    scopus 로고
    • The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide
    • Wedzicha JA, Calverley PM, Seemungal TA, Hagan G, Ansari Z, Stockley RA The prevention of chronic obstructive pulmonary disease exacerbations by salmeterol/fluticasone propionate or tiotropium bromide. Am J Respir Crit Care Med 2008, 177:19-26.
    • (2008) Am J Respir Crit Care Med , vol.177 , pp. 19-26
    • Wedzicha, J.A.1    Calverley, P.M.2    Seemungal, T.A.3    Hagan, G.4    Ansari, Z.5    Stockley, R.A.6
  • 24
    • 84877131237 scopus 로고    scopus 로고
    • Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study
    • Wedzicha JA, Decramer M, Ficker JH, et al. Analysis of chronic obstructive pulmonary disease exacerbations with the dual bronchodilator QVA149 compared with glycopyrronium and tiotropium (SPARK): a randomised, double-blind, parallel-group study. Lancet Respir Med 2013, 1:199-209.
    • (2013) Lancet Respir Med , vol.1 , pp. 199-209
    • Wedzicha, J.A.1    Decramer, M.2    Ficker, J.H.3
  • 25
    • 77953028976 scopus 로고    scopus 로고
    • The short, the long, and the "ultra-long": Why duration of bronchodilator action matters in chronic obstructive pulmonary disease
    • Beeh KM, Beier J The short, the long, and the "ultra-long": Why duration of bronchodilator action matters in chronic obstructive pulmonary disease. Adv Ther 2010, 27:150-159.
    • (2010) Adv Ther , vol.27 , pp. 150-159
    • Beeh, K.M.1    Beier, J.2
  • 27
    • 26944437890 scopus 로고    scopus 로고
    • Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients
    • Profita M, Giorgi RD, Sala A, et al. Muscarinic receptors, leukotriene B4 production and neutrophilic inflammation in COPD patients. Allergy 2005, 60:1361-1369.
    • (2005) Allergy , vol.60 , pp. 1361-1369
    • Profita, M.1    Giorgi, R.D.2    Sala, A.3
  • 28
    • 84860350181 scopus 로고    scopus 로고
    • Beta(2) long-acting and anticholinergic drugs control TGF-beta1-mediated neutrophilic inflammation in COPD
    • Profita M, Bonanno A, Montalbano AM, et al. Beta(2) long-acting and anticholinergic drugs control TGF-beta1-mediated neutrophilic inflammation in COPD. Biochim Biophys Acta 2012, 1822:1079-1089.
    • (2012) Biochim Biophys Acta , vol.1822 , pp. 1079-1089
    • Profita, M.1    Bonanno, A.2    Montalbano, A.M.3
  • 29
    • 79955473712 scopus 로고    scopus 로고
    • Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD
    • Meyer T, Reitmeir P, Brand P, et al. Effects of formoterol and tiotropium bromide on mucus clearance in patients with COPD. Respir Med 2011, 105:900-906.
    • (2011) Respir Med , vol.105 , pp. 900-906
    • Meyer, T.1    Reitmeir, P.2    Brand, P.3
  • 30
    • 11144344144 scopus 로고    scopus 로고
    • Effects of salmeterol on cilia and mucus in COPD and pneumonia patients
    • Piatti G, Ambrosetti U, Santus P, Allegra L Effects of salmeterol on cilia and mucus in COPD and pneumonia patients. Pharmacol Res 2005, 51:165-168.
    • (2005) Pharmacol Res , vol.51 , pp. 165-168
    • Piatti, G.1    Ambrosetti, U.2    Santus, P.3    Allegra, L.4


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.